https://psiconautica.org/en/news/dea-production-quotas-2027-mdma-ibogaine-english/Psiconáuticaen2026-11-13T09:31:35+01:00DEA proposes higher 2027 production quotas for MDMA and ibogainehttps://psiconautica.org/wordpress/wp-content/uploads/2026/11/psico-daily-34298-scaled.jpg https://psiconautica.org/en/news/compass-fda-application-comp360-psilocybin-treatment-resistant-depression-english/Psiconáuticaen2026-11-13T09:31:32+01:00Compass completes its FDA application for COMP360 psilocybin in treatment-resistant depressionhttps://psiconautica.org/wordpress/wp-content/uploads/2026/11/psico-daily-34294-scaled.jpg https://psiconautica.org/en/news/psilocybin-mice-five-lab-replication-nature-neuroscience-english/Psiconáuticaen2026-11-13T09:31:28+01:00Psilocybin in mice: five labs replicate acute effects, but not persistent oneshttps://psiconautica.org/wordpress/wp-content/uploads/2026/11/psico-daily-34290.jpg